Long-Term Injection-Free Subcutaneous Delivery of Exenatide via ITCA 650 Improves Compliance and Controls Glycemic Parameters and Weight

Article Information

DOI 
http://dx.doi.org/10.1177/155989771108006
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2011 MD Conference Express

Author Information

  1. Rita Buckely
  1. Julio Rosenstock, MD
    1. Dallas Diabetes and Endocrine Center and University of Texas Southwestern Medical School, Dallas, Texas, USA
View Full Text

Article usage

AbstractFullPDF
Apr 2015500
May 2015200
Jul 2015011
Aug 2015600
Sep 20159300
Oct 2015132
Total10743

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
Long-Term Injection-Free Subcutaneous Delivery of Exenatide via ITCA 650 Improves Compliance and Controls Glycemic Parameters and Weight
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Diabetes & Endocrinology Clinical Trials
Diabetes Mellitus